Gray matter integrity predicts white matter network reorganization in multiple sclerosis.


Journal

Human brain mapping
ISSN: 1097-0193
Titre abrégé: Hum Brain Mapp
Pays: United States
ID NLM: 9419065

Informations de publication

Date de publication:
03 2020
Historique:
received: 04 07 2019
revised: 16 10 2019
accepted: 17 10 2019
entrez: 7 2 2020
pubmed: 7 2 2020
medline: 24 7 2021
Statut: ppublish

Résumé

Multiple sclerosis (MS) is a chronic inflammatory and neurodegenerative disease leading to gray matter atrophy and brain network reconfiguration as a response to increasing tissue damage. We evaluated whether white matter network reconfiguration appears subsequently to gray matter damage, or whether the gray matter degenerates following alterations in white matter networks. MRI data from 83 patients with clinically isolated syndrome and early relapsing-remitting MS were acquired at two time points with a follow-up after 1 year. White matter network integrity was assessed based on probabilistic tractography performed on diffusion-weighted data using graph theoretical analyses. We evaluated gray matter integrity by computing cortical thickness and deep gray matter volume in 94 regions at both time points. The thickness of middle temporal cortex and the volume of deep gray matter regions including thalamus, caudate, putamen, and brain stem showed significant atrophy between baseline and follow-up. White matter network dynamics, as defined by modularity and distance measure changes over time, were predicted by deep gray matter volume of the atrophying anatomical structures. Initial white matter network properties, on the other hand, did not predict atrophy. Furthermore, gray matter integrity at baseline significantly predicted physical disability at 1-year follow-up. In a sub-analysis, deep gray matter volume was significantly related to cognitive performance at baseline. Hence, we postulate that atrophy of deep gray matter structures drives the adaptation of white matter networks. Moreover, deep gray matter volumes are highly predictive for disability progression and cognitive performance.

Identifiants

pubmed: 32026599
doi: 10.1002/hbm.24849
pmc: PMC7268008
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

917-927

Informations de copyright

© 2019 The Authors. Human Brain Mapping published by Wiley Periodicals, Inc.

Références

Neurology. 2012 Oct 23;79(17):1754-61
pubmed: 23019265
Mult Scler. 2017 Mar;23(3):432-441
pubmed: 27246143
Hum Brain Mapp. 2020 Mar;41(4):917-927
pubmed: 32026599
Neuroimage. 2010 Sep;52(3):1059-69
pubmed: 19819337
Mult Scler. 2016 Jan;22(1):36-42
pubmed: 25921038
Magn Reson Med. 2000 Oct;44(4):625-32
pubmed: 11025519
Neuroimage. 2015 Jun;113:184-95
pubmed: 25776214
Neuroimage. 2010 Dec;53(4):1181-96
pubmed: 20637289
Ann Neurol. 2018 Feb;83(2):210-222
pubmed: 29331092
Phys Rev Lett. 2001 Nov 5;87(19):198701
pubmed: 11690461
Mult Scler. 2015 Sep;21(10):1280-90
pubmed: 25583833
Neurosci Biobehav Rev. 2017 Dec;83:568-578
pubmed: 28890199
Front Neurosci. 2016 Feb 02;10:14
pubmed: 26869873
Sci Rep. 2016 Jul 12;6:29383
pubmed: 27403924
Neuroimage. 2012 Feb 15;59(4):3774-83
pubmed: 22119648
J Neuroimaging. 2001 Apr;11(2):129-36
pubmed: 11296581
Hum Brain Mapp. 2016 May;37(5):1866-79
pubmed: 26920497
J Neurol Sci. 2015 Nov 15;358(1-2):236-42
pubmed: 26359854
Mult Scler. 2015 Dec;21(14):1771-80
pubmed: 25791368
J Neurol. 2004 Oct;251(10):1208-14
pubmed: 15503099
J Neuropsychiatry Clin Neurosci. 2017 Spring;29(2):119-127
pubmed: 27899053
Hum Brain Mapp. 1999;8(4):272-84
pubmed: 10619420
Biophys J. 1994 Jan;66(1):259-67
pubmed: 8130344
J Neurol Neurosurg Psychiatry. 2019 Feb;90(2):219-226
pubmed: 30467210
Neuroimage. 2012 Jul 16;61(4):1402-18
pubmed: 22430496
J Neurol Sci. 2014 Jul 15;342(1-2):62-8
pubmed: 24819917
Ann Neurol. 2011 Feb;69(2):292-302
pubmed: 21387374
Hum Brain Mapp. 2009 Sep;30(9):2852-61
pubmed: 19172648
Proc Natl Acad Sci U S A. 2006 Jun 6;103(23):8577-82
pubmed: 16723398
Neuroscience. 2019 Apr 1;403:35-53
pubmed: 29101079
Mult Scler. 2017 Feb;23(2):193-194
pubmed: 27932693
Neurology. 1983 Nov;33(11):1444-52
pubmed: 6685237
Neuroimage Clin. 2016 Dec 05;13:288-296
pubmed: 28050344
Mult Scler. 2016 Sep;22(10):1279-88
pubmed: 26564997
J Neurol Sci. 2009 Jul 15;282(1-2):61-6
pubmed: 19394969
Magn Reson Med. 2003 Nov;50(5):1077-88
pubmed: 14587019
Neuroimage. 2006 Dec;33(4):1093-103
pubmed: 17011792
Brain Topogr. 2018 Mar;31(2):311-321
pubmed: 28986718
Neuroimage. 2006 Jul 1;31(3):968-80
pubmed: 16530430
J Neuroimmunol. 2011 May;234(1-2):7-18
pubmed: 21474189
Ther Adv Neurol Disord. 2019 Apr 24;12:1756286419838673
pubmed: 31040880
Mult Scler. 2016 Jun;22(7):901-9
pubmed: 26432859
AJNR Am J Neuroradiol. 2017 Jan;38(1):18-24
pubmed: 27686487
Arch Clin Neuropsychol. 2004 Mar;19(2):203-14
pubmed: 15010086
Brain. 2016 Jan;139(Pt 1):115-26
pubmed: 26637488
Neuroimage. 2011 Jul 1;57(1):19-21
pubmed: 21376812
Cereb Cortex. 2011 Nov;21(11):2565-77
pubmed: 21467209
Mult Scler. 2017 Feb;23(2):191-193
pubmed: 27932694
Neuron. 2002 Jan 31;33(3):341-55
pubmed: 11832223
Mult Scler. 2020 Apr;26(4):442-456
pubmed: 30799709

Auteurs

Angela Radetz (A)

Department of Neurology and Neuroimaging Center (NIC) of the Focus Program Translational Neuroscience (FTN), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.

Nabin Koirala (N)

Department of Neurology and Neuroimaging Center (NIC) of the Focus Program Translational Neuroscience (FTN), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.

Julia Krämer (J)

Department of Neurology, University of Münster, Münster, Germany.

Andreas Johnen (A)

Department of Neurology, University of Münster, Münster, Germany.

Vinzenz Fleischer (V)

Department of Neurology and Neuroimaging Center (NIC) of the Focus Program Translational Neuroscience (FTN), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.

Gabriel Gonzalez-Escamilla (G)

Department of Neurology and Neuroimaging Center (NIC) of the Focus Program Translational Neuroscience (FTN), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.

Manuela Cerina (M)

Department of Neurology, University of Münster, Münster, Germany.

Muthuraman Muthuraman (M)

Department of Neurology and Neuroimaging Center (NIC) of the Focus Program Translational Neuroscience (FTN), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.

Sven G Meuth (SG)

Department of Neurology, University of Münster, Münster, Germany.

Sergiu Groppa (S)

Department of Neurology and Neuroimaging Center (NIC) of the Focus Program Translational Neuroscience (FTN), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH